Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tetralone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105936623B reveals a mild copper-catalyzed route to 3,4-cyclopentyl-1-tetralone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.